Identification of tear biomarkers as broad-spectrum readouts of chemical injury
Active Definitive Contract Awarded Last action
- Contract number
- HDTRA125C0003
- Awardee
-
Wake Forest University Health Sciences UEI SN7KD2UK7GC5
- Awarding agency
-
Defense Threat Reduction Agency
Department of Defense
- Obligated
- $1,040,378
Award facts
- Opportunity
-
- FY2022-2026 DTRA Chemical / Biological Technologies Broad Agency Announcement Synopsis Pre-Solicitation · HDTRA122S0002 · Posted May 9, 2022
- Contract value 40% obligated
-
- $2,033,426.37 Current, with exercised options
- $2,579,853.29 Potential, with all options
- Completion date 55% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Basic Research
- Pricing
- Cost No Fee
- Place of performance
- Winston-Salem, NC 27157, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Funding Only Action | $690,378 | |
| Funding Only Action | $100,000 | |
| Funding Only Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $250,000 |
About this award
The Defense Threat Reduction Agency awarded a definitive contract to Wake Forest University Health Sciences for identification of tear biomarkers as broad-spectrum readouts of chemical injury on February 20, 2025, with a ceiling value of $2,579,853.29 and a cost-no-fee pricing structure.
Place of performance is Winston-Salem, NC. The work supports DTRA's chemical defense research mission by developing tear biomarkers as measurable indicators of exposure to and injury from chemical agents. The contract ultimate completion date is February 19, 2028.
Wake Forest University Health Sciences is a private nonprofit academic medical center that operates as a federal prime contractor and grant recipient across defense, civilian health, and NIH-funded biomedical research domains. The organization's relevant capability portfolio includes biomedical research in regenerative medicine and specialized clinical services, with representative federal work spanning combat medicine and tactical rescue training, longitudinal cardiovascular and aging research coordination, and large-scale clinical studies. The awardee holds major IDIQs with the National Heart Lung and Blood Institute and performs as the coordinating center for the Jackson Heart Study, a $49.5 million single-award vehicle covering core study operations and data management.
Quick answers
Who was awarded contract HDTRA125C0003?
HDTRA125C0003 was awarded to Wake Forest University Health Sciences by Defense Threat Reduction Agency (Department of Defense) on February 20, 2025.
How much is contract HDTRA125C0003 worth?
The government has obligated $1,040,378 on HDTRA125C0003. Its current value, with exercised options, is $2,033,426. Its potential value, with all options, is $2,579,853.
Was contract HDTRA125C0003 competed?
The extent of competition for HDTRA125C0003 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award